Metropolitan Life Insurance Company (MetLife)’s LeMaitre Vascular LMAT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,052	Closed	-$69.8K	–	1182
2024 Q1	$69.8K	Sell	1,052 -175	-14%	-$10.8K	﹤0.01%	1245
2023 Q4	$69.6K	Hold	1,227	–	–	﹤0.01%	1272
2023 Q3	$66.8K	Buy	1,227 +184	+18%	+$10.9K	﹤0.01%	1237
2023 Q2	$70.2K	Hold	1,043	–	–	﹤0.01%	1219
2023 Q1	$53.7K	Sell	1,043 -141	-12%	-$6.84K	﹤0.01%	1346
2022 Q4	$54.5K	Hold	1,184	–	–	﹤0.01%	1422
2022 Q3	$60K	Hold	1,184	–	–	﹤0.01%	1332
2022 Q2	$53.9K	Hold	1,184	–	–	﹤0.01%	1457
2022 Q1	$55K	Sell	1,184 -4,441	-79%	-$199K	﹤0.01%	1540
2021 Q4	$283K	Hold	5,625	–	–	﹤0.01%	1775
2021 Q3	$299K	Hold	5,625	–	–	﹤0.01%	1772
2021 Q2	$343K	Buy	5,625 +313	+6%	+$16.6K	﹤0.01%	1767
2021 Q1	$259K	Sell	5,312 -317	-6%	-$14.9K	﹤0.01%	1837
2020 Q4	$228K	Hold	5,629	–	–	﹤0.01%	1845
2020 Q3	$183K	Hold	5,629	–	–	﹤0.01%	1827
2020 Q2	$149K	Hold	5,629	–	–	﹤0.01%	2012
2020 Q1	$140K	Hold	5,629	–	–	﹤0.01%	1811
2019 Q4	$202K	Hold	5,629	–	–	﹤0.01%	1920
2019 Q3	$192K	Hold	5,629	–	–	﹤0.01%	1901
2019 Q2	$157K	Hold	5,629	–	–	﹤0.01%	2045
2019 Q1	$174K	Hold	5,629	–	–	﹤0.01%	1986
2018 Q4	$133K	Hold	5,629	–	–	﹤0.01%	2091
2018 Q3	$218K	Hold	5,629	–	–	﹤0.01%	1949
2018 Q2	$188K	Hold	5,629	–	–	﹤0.01%	1982
2018 Q1	$204K	Hold	5,629	–	–	﹤0.01%	1884
2017 Q4	$179K	Sell	5,629 -5,701	-50%	-$195K	﹤0.01%	1978
2017 Q3	$424K	Hold	11,330	–	–	﹤0.01%	1797
2017 Q2	$354K	Hold	11,330	–	–	﹤0.01%	1953
2017 Q1	$279K	Hold	11,330	–	–	﹤0.01%	2055
2016 Q4	$287K	Hold	11,330	–	–	﹤0.01%	2120
2016 Q3	$225K	Hold	11,330	–	–	﹤0.01%	2262
2016 Q2	$162K	Buy	11,330 +1,826	+19%	+$27.9K	﹤0.01%	2466
2016 Q1	$148K	Hold	9,504	–	–	﹤0.01%	2348
2015 Q4	$164K	Buy	+9,504	New	+$138K	﹤0.01%	2383

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s LMAT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of LeMaitre Vascular (LMAT) in Q2 2024, closing a stake of 1,052 shares — an estimated $69.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in LMAT in Q4 2015 and held it in 34 quarters. The position peaked at $424K in Q3 2017. 261 funds tracked by Wall St. Rank hold LMAT as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining LeMaitre Vascular position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,052 LeMaitre Vascular shares in Q2 2024, an estimated $69.8K.
Metropolitan Life Insurance Company (MetLife) first reported a position in LeMaitre Vascular in Q4 2015 and held it in 34 quarters.
Metropolitan Life Insurance Company (MetLife)'s LeMaitre Vascular position peaked at $424K in Q3 2017.
261 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.